1. A Comparison of Current Guidelines of Five International Societies on Clostridium difficile Infection Management

   • Csaba Fehér
   • Josep Mensa

   Review Open access 28 July 2016 Pages: 207 - 230

2. Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review

   • Lauren E. Bloomfield
   • Thomas V. Riley

   Review Open access 01 July 2016 Pages: 231 - 251

   

3. Clostridium difficile Infection in Special High-Risk Populations

   • Alberto Cózar-Llistó
   • Antonio Ramos-Martinez
   • Javier Cobo

   Review Open access 11 August 2016 Pages: 253 - 269

4. Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

   • Louis Bont
   • Paul A. Checchia
   • Xavier Carbonell-Estrany

   Review Open access 01 August 2016 Pages: 271 - 298

   

5. Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need

   • Monique R. Bidell
   • Milena McLaughlin
   • Nimish Patel

   Review Open access 06 July 2016 Pages: 299 - 312

6. Hepatitis C Therapy in Renal Patients: Who, How, When?

   • Corinne Isnard Bagnis
   • Patrice Cacoub

   Review Open access 07 July 2016 Pages: 313 - 327

7. New Antiretroviral Treatment for HIV

   • Melissa E. Badowski
   • Sarah E. Pérez
   • John A. Littler

   Review Open access 18 August 2016 Pages: 329 - 352

8. Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

   • Daniel H. Deck
   • Jennifer M. Jordan
   • G. Ralph Corey

   Original Research Open access 01 July 2016 Pages: 353 - 361

   

9. Erratum to: Single-Dose Oritavancin Treatment of Acute Bacterial Skin and Skin Structure Infections: SOLO Trial Efficacy by Eron Severity and Management Setting

   • Daniel H. Deck
   • Jennifer M. Jordan
   • G. Ralph Corey

   Erratum Open access 26 August 2016 Pages: 363 - 365

10. Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus

    • Juwon Yim
    • Jordan R. Smith
    • Michael J. Rybak

    Original Research Open access 18 July 2016 Pages: 367 - 377

    

11. Molecular Characterization of Invasive Carbapenem-Resistant Acinetobacter baumannii from a Tertiary Care Hospital in South India

    • Saranya Vijayakumar
    • Radha Gopi
    • Balaji Veeraraghavan

    Original Research Open access 23 August 2016 Pages: 379 - 387

12. Maraviroc Intensification Improves Endothelial Function in Abacavir-Treated Patients, an Open-Label Randomized Cross-Over Pilot Study

    • Maaike Krikke
    • Kiki Tesselaar
    • Andy I. M. Hoepelman

    Original Research Open access 14 June 2016 Pages: 389 - 404

    

13. Erratum to: In Vitro Activity of Oral Antimicrobial Agents against Pathogens Associated with Community-Acquired Upper Respiratory Tract and Urinary Tract Infections: A Five Country Surveillance Study

    • Douglas J. Biedenbach
    • Robert E. Badal
    • Stephen Marcella

    Erratum Open access 16 July 2016 Pages: 405 - 405